Product Information
LYRICA 75 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.6710 per EA under NDC 58151023888. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on Dec 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151023888
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446FDA Approved
12/30/2004
TE Code
AB
On Market Since
6/17/2025
Price Statistics
The NADAC for LYRICA 75 MG CAPSULE has been published 49 times since Oct 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6710 per EA |
|---|---|
| All-time high | $9.7419 (Nov 12, 2025) |
| All-time low | $9.6710 (Sep 23, 2026) |
| 52-week high | $9.7419 |
| 52-week low | $9.6710 |
| Median price | $9.7211 |
| Average price | $9.7041 |
| Largest weekly change | -0.6% (Nov 19, 2025) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PREGABALIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LYRICA 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 75 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.6710 per EA (NDC 58151023888), effective Sep 30, 2026.
How has the price of LYRICA 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 75 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for LYRICA 75 MG CAPSULE?
Since Oct 29, 2025, the NADAC for LYRICA 75 MG CAPSULE has ranged from a low of $9.6710 (Sep 23, 2026) to a high of $9.7419 (Nov 12, 2025), with a median of $9.7211 per EA.
Are there cheaper alternatives to LYRICA 75 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 75 MG CAPSULE, is $0.0528 per EA — about 99% below LYRICA 75 MG CAPSULE.
Who manufactures LYRICA 75 MG CAPSULE?
LYRICA 75 MG CAPSULE (NDC 58151023888) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.